Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer’s Disease Neuroimaging Initiative cohort

Overview of attention for article published in Scientific Reports, April 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

news: 1 news outlet
policy: 1 policy source

twitter: 5 X users

Readers on

mendeley: 53 Mendeley

So far, Altmetric has seen 2 policy documents that reference this research output.

Health System Readiness for Disease-Modifying Therapies for Alzheimer's Disease - Final Report

Cited by Canadian Agency for Drugs and Technologies in Health (CADTH) on 04 Dec 2024

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

Health System Readiness for Disease-Modifying Therapies for Alzheimer's Disease - Draft Report

Cited by Canadian Agency for Drugs and Technologies in Health (CADTH) on 08 Jul 2024

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.